An AstraZeneca spokeswoman said ... for many years a hub of the group’s research. The closure, while offset by the Cambridge investment, was ...

AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugmaker CSPC Pharmaceutical Group, the ...

AstraZeneca has revealed the ... located in the heart of the city on the Cambridge Biomedical Campus (CBC), is also intended to be a hub for external collaborations and partnerships – now ...

Frontier IP, a specialist in commercialising intellectual property is working in partnership to create a novel innovation hub ...

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge ... could one day become a biotech hub to rival Boston and San Francisco in ...

AstraZeneca Plc will invest £650 million ($827 million) into Britain, expanding its Cambridge base and building a vaccine manufacturing plant near Liverpool. The drug-maker, which partnered with ...

It joins a cluster of businesses seeking to make Cambridge a hub for life sciences research ... which promotes business development in the city. AstraZeneca worked with Oxford University to ...

Catalyst Innovation Hub will embrace new technology including AI ... and Respiratory&Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are ...

LONDON (Reuters) – AstraZeneca is closing ... for many years a hub of the group’s research. The closure, while offset by the Cambridge investment, was also a blow to the British government.